There’s an FDA-sanctioned video game now
After years of development and a few months of uncertainty, the FDA has given the green light to EndeavorRx, a video game meant to treat ADHD and the first digital therapeutic to pass regulatory muster in the U.S.
As STAT’s Rebecca Robbins reports, the game, developed by Boston-based Akili Interactive Labs, targets children between the ages of 8 and 12 who have an ADHD diagnosis and have demonstrated an issue with attention. EndeavorRx rewards players for completing various tasks designed to activate and strengthen certain neural networks in the brain. It’s a far more ambitious application of technology than the many apps designed to help patients manage their conditions, and its approval is a landmark moment for the health tech sector.
It’s also just the beginning of Akili’s story. Now the company has to convince doctors to prescribe it, insurers to pay for it, and patients to stick to it. The company’s success or failure will be closely watched by a nascent industry.
Read more.
As STAT’s Rebecca Robbins reports, the game, developed by Boston-based Akili Interactive Labs, targets children between the ages of 8 and 12 who have an ADHD diagnosis and have demonstrated an issue with attention. EndeavorRx rewards players for completing various tasks designed to activate and strengthen certain neural networks in the brain. It’s a far more ambitious application of technology than the many apps designed to help patients manage their conditions, and its approval is a landmark moment for the health tech sector.
It’s also just the beginning of Akili’s story. Now the company has to convince doctors to prescribe it, insurers to pay for it, and patients to stick to it. The company’s success or failure will be closely watched by a nascent industry.
Read more.
.png)
No hay comentarios:
Publicar un comentario